Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Nissen

Showing results (11-20 of 683) with videos related to

Pageof 69
Sort By:
Journal of the American College of Cardiology|February 6, 2007
President's page: the ACC's international mission: learning, leading, and sharingSteven E Nissen
Lancet (London, England)|December 13, 2006
The DREAM trialSteven E Nissen
The New England Journal of Medicine|June 28, 2006
Adverse cardiovascular effects of rofecoxibSteven E Nissen
BMJ (Clinical Research Ed.)|December 17, 2013
Rosiglitazone: a case of regulatory hubrisSteven E Nissen
Annals of Internal Medicine|May 8, 2023
Comparative Effectiveness of Diabetes Drugs: The Use and Misuse of Observational ResearchSteven E Nissen
Current Cardiology Reports|October 28, 2008
Rationale for cardiovascular medicine to separate from internal medicine and become an independent specialtySteven E Nissen
Annals of Internal Medicine|January 20, 2016
U.S. Dietary Guidelines: An Evidence-Free ZoneSteven E Nissen
JAMA Internal Medicine|October 7, 2014
Prevention guidelines: bad process, bad outcomeSteven E Nissen
Annals of Internal Medicine|March 7, 2018
Statin Denial: An Internet-Driven Cult With Deadly ConsequencesSteven E Nissen
European Heart Journal|February 16, 2010
The rise and fall of rosiglitazoneSteven E Nissen
Pageof 69

Showing results (11-20 of 683) with videos related to

Sort By:
Pageof 69
Journal of the American College of Cardiology|February 6, 2007
President's page: the ACC's international mission: learning, leading, and sharingSteven E Nissen
Lancet (London, England)|December 13, 2006
The DREAM trialSteven E Nissen
The New England Journal of Medicine|June 28, 2006
Adverse cardiovascular effects of rofecoxibSteven E Nissen
BMJ (Clinical Research Ed.)|December 17, 2013
Rosiglitazone: a case of regulatory hubrisSteven E Nissen
Annals of Internal Medicine|May 8, 2023
Comparative Effectiveness of Diabetes Drugs: The Use and Misuse of Observational ResearchSteven E Nissen
Current Cardiology Reports|October 28, 2008
Rationale for cardiovascular medicine to separate from internal medicine and become an independent specialtySteven E Nissen
Annals of Internal Medicine|January 20, 2016
U.S. Dietary Guidelines: An Evidence-Free ZoneSteven E Nissen
JAMA Internal Medicine|October 7, 2014
Prevention guidelines: bad process, bad outcomeSteven E Nissen
Annals of Internal Medicine|March 7, 2018
Statin Denial: An Internet-Driven Cult With Deadly ConsequencesSteven E Nissen
European Heart Journal|February 16, 2010
The rise and fall of rosiglitazoneSteven E Nissen
Pageof 69